Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective oral delivery, today announced that two abstracts ...

She completed advanced fellowships in hepatology/transplant and gastroenterology, with clinical expertise in colorectal cancer screening, liver diseases (including cirrhosis and hepatitis), ...

Galectin's belapectin shows promise in MASH cirrhosis despite setbacks. High-risk investment with upcoming FDA meeting ...

Fact checked by Jennifer Klump Key Takeaways The FDA approved the obesity drug Wegovy as a treatment for people with MASH ...

Rosa Tellez-Moore finds hope and healing through groundbreaking research at UC San Diego Health Rosa Tellez-Moore is grateful ...

Serious infections significantly increase the mortality risk among adults with chronic liver disease, including those without cirrhosis.

Thousands more people in England have been referred for liver cancer checks thanks to the expansion of an NHS scheme that ...